Additionally, MAM has been implicated in the pathogenesis and progression of cardiovascular diseases, endocrine and metabolic disorders, and neurodegenerative diseases, making them significant targets in the treatment of these conditions [9–11]. The gene discussed is SGCG; the disease is metabolic disease.